TCL Archive NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification April 10, 1981
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Greenwald Disagrees With WHT Report But Won’t Fight Decision; Will Ask For Limited Study, With Scope To Be Modified January 15, 1988